Seqirus AFLURIA QUADRIVALENT 0.5ml , 10 Pre-filled Syringes
$235.00
AFLURIA QUADRIVALENT
Description
AFLURIA QUADRIVALENT
Key Features
- Administer as a 0.25-mL dose for patients 6 through 35 months, and as a 0.5-mL dose for patients 36 months through 8 years as 1 or 2* doses1
- Demonstrated immunogenicity in children and adults1
- Demonstrated safety profile1
- Produced through traditional egg-based manufacturing1
*1 or 2 doses depends on vaccination history as per Advisory Committee on Immunization Practices annual recommendations on prevention and control of influenza with vaccines.